UCLA researchers report that although the majority of medical journals have conflict of interest policies in place for study authors, less than half require such policies for editors or peer-reviewers. In addition, many journals do not inform readers about those potential conflicts that have been disclosed to them.
A new study has suggested a novel way of combating diseases related to the immune system, including cancer and autoimmune diseases such as type I diabetes and arthritis. The study, funded by the Wellcome Trust, appears online in the journal Nature.
About one-third of heart attack patients do not receive treatment to open blocked arteries within the recommended 12-hour timeframe after a heart attack. Treatment such as angioplasty or clot-busting drugs may not be given because patients arrive at the hospital too late.
In the days following a heart attack, patients who have no or mild symptoms and undergo a procedure called angioplasty to mechanically open their totally blocked coronary arteries do not reduce their risk of having another heart attack, going into heart failure or dying, according to the results of a new study.
Amgen (NASDAQ: AMGN) announced Enbrel (R) (etanercept) is the first biologic with published data to show sustained improvements in multiple efficacy measures in rheumatoid arthritis patients completing up to nine years of therapy. Current data suggest Enbrel is both effective and safe in long-term RA use, and the new data, presented at the American College of Rheumatology scientific meeting, provide a degree of reassurance that unexpected safety concerns do not appear to develop after nine years of use.
A study of healthy women has harvested results involving fatigue and vigor that eventually may help researchers fine tune efforts to treat a multitude of illnesses and syndromes linked to low levels of the stress hormone cortisol.
Researchers today presented data showing that ACTOS (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid intima-media thickness (CIMT) in patients with type 2 diabetes. Results from the clinical trial, CHICAGO (Carotid intima-media thickness in Atherosclerosis using pioglitazone), are part of a late-breaker presentation at the American Heart Association’s Scientific Sessions 2006, coincidentally being held in Chicago, and coincide with an early online issue of the Journal of the American Medical Association.
Mary Lee Dequeant, Ph.D., a Predoctoral Researcher at the Stowers Institute for Medical Research, and Olivier Pourqui?, Ph.D., Stowers Institute Investigator and an investigator with the Howard Hughes Medical Institute, are the first and last authors, respectively, on a paper that identifies a network of cyclic genes that shed light on the molecular basis of spine formation in the embryo.
University of Iowa scientists have made a discovery that broadens understanding of a rapidly developing area of biology known as functional genomics and sheds more light on the mysterious, so-called “junk DNA” that makes up the majority of the human genome.
Six percent of obese kidney transplant patients die in the first year and 14 percent suffer transplant failures. The figures for non obese patients are three percent and eight percent. Experts from seven university hospitals in the Netherlands studied 2067 patients. Their finding appear in the November issue of Transplant International.